What is NDC 70771-1710?

70771-1710 is the product NDC for Oseltamivir Phosphate, Oseltamivir phosphate 30 mg/1 capsule, listed with the FDA by Zydus Lifesciences Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Oseltamivir Phosphate?

105 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Oseltamivir Phosphate NDC 70771-1710 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1710Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1710Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70771-1710-2	70771171002	1 BLISTER PACK in 1 CARTON (70771-1710-2) / 10 CAPSULE in 1 BLISTER PACKMarketed from Feb 24, 2017

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Oseltamivir Phosphate
Generic name (nonproprietary): oseltamivir phosphate
Active ingredients: Oseltamivir phosphate — 30 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Zydus Lifesciences LimitedNDC labeler code 70771
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208578
Marketing start: Feb 24, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Neuraminidase Inhibitors (Mechanism)
Identifiers: Product ID 70771-1710_1e8d55a0-7d87-4135-886c-d0e6591d9917SPL ID 1e8d55a0-7d87-4135-886c-d0e6591d9917SPL set ID 58118069-cb24-4fa3-92d7-cabdc1b027f2RxCUI 312122, 728109, 728113UNII 4A3O49NGEZ
Pharmacologic class: Neuraminidase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771171002 followed by a unit qualifier and the quantity

Package 70771-1710-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 3, 2024.

Full label on DailyMed (opens in a new tab)

About NDC 70771-1710

What is NDC 70771-1710?: 70771-1710 is the product NDC for Oseltamivir Phosphate, Oseltamivir phosphate 30 mg/1 capsule, listed with the FDA by Zydus Lifesciences Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Oseltamivir Phosphate.
What is the active ingredient?: Oseltamivir phosphate.
Who is the labeler?: Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Oseltamivir Phosphate?: 105 other product NDCs are listed under this name. See all Oseltamivir Phosphate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Oseltamivir Phosphate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Oseltamivir Phosphate	Oseltamivir phosphate 6 mg/mL	For suspensionOral	Alembic Pharmaceuticals Limited	46708-769	46708-0769-60
Oseltamivir Phosphate	Oseltamivir phosphate 6 mg/mL	For suspensionOral	Alembic Pharmaceuticals Inc.	62332-769	62332-0769-60
Oseltamivir Phosphate	Oseltamivir phosphate 6 mg/mL	SuspensionOral	HEC Pharm USA Inc.	72303-0851	72303-0851-01
Oseltamivir Phosphate	Oseltamivir phosphate 75 mg/1	CapsuleOral	Preferred Pharmaceuticals Inc.	68788-4066	68788-4066-01
oseltamivir phosphate	Oseltamivir phosphate 30 mg/1	CapsuleOral	Zhejiang Poly Pharm. Co., Ltd.	72673-101	72673-0101-10
oseltamivir phosphate	Oseltamivir phosphate 45 mg/1	CapsuleOral	Zhejiang Poly Pharm. Co., Ltd.	72673-102	72673-0102-10
Oseltamivir phosphate	Oseltamivir phosphate 30 mg/1	CapsuleOral	Shandong New Time Pharmaceutical Co., Ltd.	42677-320	42677-0320-01
Oseltamivir phosphate	Oseltamivir phosphate 45 mg/1	CapsuleOral	Shandong New Time Pharmaceutical Co., Ltd.	42677-321	42677-0321-01
Oseltamivir phosphate	Oseltamivir phosphate 75 mg/1	CapsuleOral	Shandong New Time Pharmaceutical Co., Ltd.	42677-322	42677-0322-01
Oseltamivir phosphate	Oseltamivir phosphate 75 mg/1	CapsuleOral	Preferred Pharmaceuticals Inc.	68788-8831	68788-8831-01

All 106 Oseltamivir Phosphate NDCs

Other NDCs under ANDA 208578

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208578
Product	Strength	Form · route	Labeler	Product NDC
Oseltamivir Phosphate	Oseltamivir phosphate 75 mg/1	CapsuleOral	Redpharm Drug	67296-1923
Oseltamivir Phosphate	Oseltamivir phosphate 75 mg/1	CapsuleOral	Preferred Pharmaceuticals Inc.	68788-4066
Oseltamivir Phosphate	Oseltamivir phosphate 30 mg/1	CapsuleOral	Zydus Pharmaceuticals USA Inc.	70710-1008
Oseltamivir Phosphate	Oseltamivir phosphate 45 mg/1	CapsuleOral	Zydus Pharmaceuticals USA Inc.	70710-1009
Oseltamivir Phosphate	Oseltamivir phosphate 75 mg/1	CapsuleOral	Zydus Pharmaceuticals USA Inc.	70710-1010
Oseltamivir Phosphate	Oseltamivir phosphate 45 mg/1	CapsuleOral	Zydus Lifesciences Limited	70771-1711
Oseltamivir Phosphate	Oseltamivir phosphate 75 mg/1	CapsuleOral	Zydus Lifesciences Limited	70771-1712